Related Experiment Video

Updated: Sep 26, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

HAV infection in chronic liver disease: a rationale for vaccination

Piero L Almasio1, Pietro Amoroso

  • 1Cattedra di Gastroenterologia, University of Palermo, Clinica Medica I, Piazza delle Cliniche 2, 90127 Palermo, Italy. palmasio@unipa.it

Vaccine
|May 15, 2003
PubMed

Insights

Hepatitis A virus (HAV) infection does not worsen liver disease. Vaccination against HAV is recommended for individuals with chronic liver disease, particularly those under 40.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis A virus (HAV) is a significant cause of acute liver inflammation.
  • The impact of HAV exposure on pre-existing chronic liver diseases requires thorough investigation.
  • Assessing natural immunity trends against HAV is crucial for public health strategies.

Purpose of the Study:

  • To systematically evaluate the literature on whether HAV exposure can lead to fatal deterioration in patients with liver diseases.
  • To analyze the safety and efficacy of HAV vaccination in individuals with chronic liver conditions.

Main Methods:

  • A systematic literature search was conducted to identify relevant studies.
  • Thirty studies were assessed to synthesize evidence regarding HAV exposure and liver disease.
  • Data on natural immunity trends and vaccine safety in specific populations were analyzed.

Main Results:

  • The literature review did not find evidence that HAV exposure induces fatal deterioration of liver diseases.
  • A progressive decrease in natural immunity against HAV was observed in Italy.
  • Hepatitis A virus (HAV) vaccination demonstrated comparable safety in individuals with chronic liver diseases to that in the general population.

Conclusions:

  • HAV infection is not associated with fatal outcomes in patients with liver diseases.
  • Vaccination against HAV is a safe and recommended preventive measure for individuals with chronic liver disease.
  • Hepatitis A virus (HAV) vaccination is particularly recommended for those with chronic liver disease under the age of 40.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Vaccinations01:51

Vaccinations

Overview
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...